Understanding Bio-Based Chemicals and Their Importance

Q: What are bio-based chemicals and enzymes , and how do they differ from conventional petrochemicals?

Bio-based chemicals are industrial chemicals derived from renewable biological feedstocks such as sugarcane, corn, starch, and agricultural residues. They are typically produced through fermentation or enzymatic processes rather than through fossil-fuel-based refining. Examples include lactic acid, bio-alcohols, solvents, surfactants, and intermediates used in plastics and pharmaceuticals. Enzymes, which are biological catalysts, play a crucial role in these processes by enabling chemical reactions at lower temperatures and pressures, thereby reducing energy consumption and emissions.In contrast, conventional petrochemicals are derived from crude oil or natural gas and often involve energy-intensive processes with higher carbon footprints. Bio-based alternatives align with circular economy principles by utilizing renewable inputs and sometimes agricultural waste. For instance, ethanol-based chemicals produced by companies like Godavari Biorefineries demonstrate how agricultural feedstock can substitute petroleum-derived intermediates. Thus, the shift toward bio-based chemicals represents not merely a technological change but a structural transition toward sustainable industrial production.

Q: What lessons can India learn from international experiences in promoting bio-based chemicals?

Global experiences provide valuable policy insights. The European Union’s Bioeconomy Strategy integrates industrial policy with climate and circular economy goals, ensuring coordinated funding and regulatory support. Similarly, the U.S. USDA BioPreferred Program mandates federal procurement preference for certified bio-based products, thereby creating assured demand.China and Japan have prioritized bio-based chemicals within national innovation strategies, linking research funding with manufacturing readiness. India can adopt similar approaches by combining R&D incentives, procurement mandates, and certification standards. For example, preferential procurement of bio-based detergents or packaging materials in government contracts could create early markets and attract private investment.

Exploring how India's agricultural strength can boost the bio-based chemicals and enzymes sector for sustainable growth.

Gopi

•February 16, 2026•5 mins read

India pushes bio-based chemicals and enzymes to cut imports, boost green manufacturing, and strengthen its bioeconomy under the BioE3 policy

Not Started

1. Concept and Industrial Significance

Bio-based chemicals are industrial chemicals derived from biological feedstocks such as sugarcane, corn, starch, and biomass residues, often produced through fermentation or enzymatic processes. They include organic acids (e.g., lactic acid), bio-alcohols, solvents, surfactants, and intermediates used in plastics, cosmetics, and pharmaceuticals.

Enzymes are biological catalysts that accelerate chemical reactions under milder conditions of temperature and pressure. They are widely used in detergents, food processing, textiles, pulp and paper, pharmaceuticals, and increasingly in advanced biomanufacturing. Their use reduces energy consumption and lowers industrial emissions.

The shift toward bio-based inputs represents a structural transition from fossil-fuel-based petrochemicals to renewable and circular production systems. This transition aligns with climate commitments, resource efficiency goals, and sustainable industrialisation.

The governance logic lies in aligning industrial growth with environmental sustainability. If India remains dependent on petrochemical pathways, it risks higher import bills, carbon-intensive growth, and technological lag in emerging green industries.

2. Why India Needs Bio-based Chemicals

India possesses structural advantages for scaling bio-based chemicals and enzymes. It has a large agricultural base capable of supplying feedstock, established expertise in fermentation through its pharmaceutical and vaccine sectors, and a rapidly expanding manufacturing ecosystem.

Expanding this sector can reduce dependence on imported petrochemicals while creating value-added markets for agricultural produce. This supports rural incomes, industrial diversification, and supply chain resilience.

For instance:

India imported approximately $479.8 million worth of acetic acid in 2023

Reducing such imports through domestic bio-based alternatives would strengthen the trade balance and enhance economic security.

Moreover, bio-based chemicals can position India as a competitive global supplier of sustainable industrial inputs, particularly as global markets increasingly favour low-carbon and circular products.

The developmental logic is that bio-based chemicals integrate agriculture, industry, and sustainability. If India does not leverage its bio-resource base, it may lose competitive advantage to countries already scaling bioeconomy ecosystems.

3. India’s Current Policy and Industry Landscape

Bio-based chemicals and enzymes have been prioritised under the Department of Biotechnology’s BioE3 (Biotechnology for Economy, Environment, and Employment) policy. The policy aims to support high-value biomanufacturing and build shared infrastructure such as biofoundries, pilot plants, and demonstration facilities.

In the bio-based chemicals segment:

Praj Industries and Godrej Industries are major players
Godavari Biorefineries focuses on ethanol-based bio-derived chemicals
Jubilant Ingrevia produces acetyl intermediates (e.g., acetic anhydride, ethyl acetate)
Emerging firms like StringBio are using novel microbial technologies

In the enzymes market:

The sector is highly consolidated, with top players accounting for more than 75% of market share
Key companies include Novozymes India, DuPont, DSM, Advance Enzyme Technologies, BASF SE, and Ultreze Enzymes

Despite these strengths, the ecosystem remains in early stages of scaling relative to global leaders.

Policy support is critical in early-stage sectors where private investment alone may be insufficient. Without coordinated industrial strategy, India’s bioeconomy potential may remain fragmented and under-scaled.

4. Global Approaches: Comparative Policy Lessons

Major economies are integrating bio-based chemicals within broader industrial and climate strategies.

European Union: The EU Bioeconomy Strategy links industrial transformation with circular economy goals, climate mitigation, and waste reduction. It provides coordinated policy and regulatory support.
United States: The USDA BioPreferred Program mandates federal procurement preference for certified bio-based products, thereby creating assured demand and early markets.
China: Bioeconomy development plans prioritise high-value bio-based chemicals and enzyme technologies as strategic sectors.
Japan: METI and NARO fund projects that integrate research with manufacturing readiness, ensuring smoother commercialisation pathways.

These models show that public procurement, regulatory clarity, and R&D integration are central to sectoral growth.

Strategic state support reduces market uncertainty and accelerates scale-up. If India does not adopt similar demand-creation and innovation-linked policies, domestic firms may struggle to compete globally.

5. Key Risks and Structural Challenges

- Cost Competitiveness

Bio-based chemicals often face higher initial costs compared to petrochemical alternatives. Though such disadvantages may reduce with scale and technological maturity, they pose entry barriers for private investment.

- Feedstock and Infrastructure Constraints

Reliable and sustainable feedstock supply chains are essential. Variability in agricultural output, logistics constraints, and inadequate processing infrastructure can hinder large-scale production.

- Market Adoption Challenges

Downstream manufacturers may hesitate to switch to bio-based inputs unless:

Performance is equivalent
Costs are comparable
Regulatory standards support substitution

Industrial inertia and supply chain rigidity can slow adoption even when alternatives are viable.

If cost, infrastructure, and adoption barriers are not addressed simultaneously, the sector risks stagnation despite policy intent. Industrial transformation requires ecosystem-wide coordination.

6. Policy Measures for Scaling the Sector

India can adopt targeted interventions to de-risk investment and accelerate adoption:

- Infrastructure Support

Establish shared biofoundries, pilot plants, and demonstration facilities under BioE3
Reduce capital expenditure burdens for start-ups and MSMEs

- Standards and Certification

Develop clear standards for bio-based content and performance
Ensure regulatory clarity to build investor and consumer confidence

- Public Procurement and Market Creation

Introduce procurement preferences for certified bio-based products
Create early demand signals similar to the U.S. BioPreferred model

- Integration with Agricultural Policy

Align feedstock planning with crop diversification and bioresource management
Support farmer participation in value chains

These measures can create a stable investment climate and accelerate the transition from pilot-scale to commercial-scale production.

The governance objective is to shift from isolated projects to a systemic bioeconomy framework. Without coordinated policy instruments, scale and competitiveness will remain elusive.

7. Cross-Dimensional Relevance for UPSC

GS Paper II (Governance & Policy)

Role of BioE3 policy
State support in emerging technology sectors
Public procurement as industrial policy tool

GS Paper III (Economy, Environment, S&T)

Industrial diversification and import substitution
Climate-friendly manufacturing
Biotechnology and innovation ecosystems
Circular economy and sustainable development

Essay & Interview

Green industrialisation
Bioeconomy as pathway to Atmanirbhar Bharat
Agriculture-industry linkages

Conclusion

Bio-based chemicals and enzymes represent a strategic convergence of agriculture, biotechnology, manufacturing, and sustainability. With appropriate infrastructure, standards, and demand-side policies, India can transition from a petrochemical-dependent system to a resilient bioeconomy model. Long-term competitiveness will depend on coordinated policy execution, ecosystem development, and integration with climate and industrial strategies.

Quick Q&A

Everything you need to know

Bio-based chemicals are industrial chemicals derived from renewable biological feedstocks such as sugarcane, corn, starch, and agricultural residues. They are typically produced through fermentation or enzymatic processes rather than through fossil-fuel-based refining. Examples include lactic acid, bio-alcohols, solvents, surfactants, and intermediates used in plastics and pharmaceuticals. Enzymes, which are biological catalysts, play a crucial role in these processes by enabling chemical reactions at lower temperatures and pressures, thereby reducing energy consumption and emissions.

In contrast, conventional petrochemicals are derived from crude oil or natural gas and often involve energy-intensive processes with higher carbon footprints. Bio-based alternatives align with circular economy principles by utilizing renewable inputs and sometimes agricultural waste. For instance, ethanol-based chemicals produced by companies like Godavari Biorefineries demonstrate how agricultural feedstock can substitute petroleum-derived intermediates. Thus, the shift toward bio-based chemicals represents not merely a technological change but a structural transition toward sustainable industrial production.

Scaling bio-based chemicals aligns with India’s twin objectives of economic self-reliance and climate sustainability. India imported nearly $479.8 million worth of acetic acid in 2023, reflecting continued dependence on petrochemical imports. Expanding domestic bio-based production can reduce import bills, enhance value addition to agricultural produce, and create rural income opportunities.

Environmentally, bio-based chemicals contribute to lower greenhouse gas emissions due to reduced energy requirements and renewable feedstocks. Under the BioE3 policy, India aims to integrate biotechnology with industrial growth. Leveraging its strengths in fermentation—demonstrated in pharmaceuticals and vaccines—India can become a global supplier of sustainable industrial inputs. This aligns with climate commitments under the Paris Agreement and supports the vision of a circular bioeconomy.

One of the primary barriers in bio-based chemical production is high initial capital investment. Establishing biofoundries, pilot plants, and demonstration facilities requires significant financial outlays, which can deter startups and MSMEs. Shared infrastructure under initiatives like BioE3 can distribute this cost across multiple firms, thereby lowering entry barriers.

Additionally, shared facilities enable faster commercialization of laboratory innovations by providing scale-up support. For example, emerging firms such as StringBio use novel microbial strategies but require pilot-scale validation before full industrial deployment. Publicly supported demonstration plants can bridge this “valley of death” between research and market readiness, fostering innovation while minimizing private risk.

Despite its promise, the bio-based chemicals sector faces structural risks. First, cost competitiveness remains a challenge. Petrochemicals benefit from established infrastructure and economies of scale, making bio-based alternatives relatively expensive during early adoption phases. Without policy incentives or carbon pricing, private investment may remain limited.

Second, feedstock reliability and market acceptance pose challenges. Fluctuations in agricultural output can disrupt supply chains. Moreover, downstream manufacturers may hesitate to switch inputs due to compatibility concerns. For example, replacing petrochemical-based solvents in established manufacturing lines requires technical adjustments. Therefore, while the sector offers sustainability benefits, its long-term viability depends on coordinated policy support, stable feedstock supply, and strong market signaling mechanisms.

Global experiences provide valuable policy insights. The European Union’s Bioeconomy Strategy integrates industrial policy with climate and circular economy goals, ensuring coordinated funding and regulatory support. Similarly, the U.S. USDA BioPreferred Program mandates federal procurement preference for certified bio-based products, thereby creating assured demand.

China and Japan have prioritized bio-based chemicals within national innovation strategies, linking research funding with manufacturing readiness. India can adopt similar approaches by combining R&D incentives, procurement mandates, and certification standards. For example, preferential procurement of bio-based detergents or packaging materials in government contracts could create early markets and attract private investment.

A comprehensive strategy would combine industrial policy, agricultural integration, and sustainability incentives. First, strengthen domestic R&D through grants and tax incentives while promoting industry-academia collaboration. Building clusters around existing leaders such as Praj Industries or Jubilant Ingrevia can create ecosystem advantages.

Second, ensure reliable feedstock supply chains by integrating farmer-producer organizations and promoting biomass aggregation systems. Introducing certification standards and green labeling can enhance consumer trust. Finally, leveraging public procurement and export promotion schemes can help Indian firms compete globally. By aligning biotechnology innovation with manufacturing competitiveness, India can position itself as a hub for sustainable industrial transformation.